Latest National Jewish Health Stories
Poorly controlled asthma more than doubles healthcare costs associated with the disease and threatens educational achievement through a dramatic increase in school absence, according to researchers at National Jewish Health. The research team reported in the August 2011 issue of The Archives of Allergy, Asthma & Immunology that children with "very poorly controlled" asthma missed an average of 18 days of school each year, compared to 2 or less for other asthma...
Researchers at National Jewish Health have discovered a type of cell that may contribute to autoimmune disease. The findings also suggest why diseases such as lupus, multiple sclerosis and rheumatoid arthritis strike women more frequently than men.The cells, a subset of immune-system B cells, make autoantibodies, which bind to and attack the body's own tissue. The researchers report in the August 4, 2011, issue of the journal Blood, that they found higher levels of these cells in elderly...
Genetic Variant Associated with MUC5B Gene ID's Major Risk Factor, Points Research in New Direction CULVER CITY, Calif., April 21, 2011/PRNewswire-USNewswire/ -- A new discovery in a deadly lung disease may change the direction of research while uncovering increased risk for many patients and families. The Coalition for Pulmonary Fibrosis (CPF) and the Pulmonary Fibrosis Foundation (PFF) applaud the efforts of scientists that led to the discovery of a genetic variation associated with the...
Potential therapeutic targets identified for deadly, untreatable lung diseaseResearchers at National Jewish Health have discovered a signaling pathway that is crucial to the devastating effects of acute lung injury (ALI). The data, obtained from cells, animals and ALI patients, suggest several potential therapeutic targets. Experimental blockade of one of the targets significantly reduced flooding of the lungs that is the hallmark of ALI."Acute lung injury is a devastating disease, with...
Researchers at National Jewish Health and the University of Texas Southwestern Medical Center have discovered a new method to fight bacterial infections associated with contact lenses. The method may also have applications for bacterial infections associated with severe burns and cystic fibrosis. The results were published online January 18 in the journal Investigative Ophthalmology and Visual Science."Infections by the bacteria Pseudomonas aeruginosa can cause severe scarring and vision loss...
DENVER, Jan. 10, 2011 /PRNewswire/ -- Building on a shared desire to bring the highest level of critical and acute care to patients with respiratory diseases and other complex medical illnesses, Colorado Acute Long Term Hospital and National Jewish Health (NJH) have developed a clinical affiliation that brings National Jewish Health expertise in respiratory and critical care to patients at Colorado Acute. "Colorado Acute is an outstanding facility known for the care it provides to patients...
Many children, especially those with eczema, are unnecessarily avoiding foods based on incomplete information about potential food-allergies, according to researchers at National Jewish Health. The food avoidance poses a nutritional risk for these children, and is often based primarily on data from blood tests known as serum immunoassays.Many factors, including patient and family history, physical examination, and blood and skin tests, should be used when evaluating potential food allergies....
Inaugural IPF Summit: From Bench to Bedside to be held in Chicago, IL December 1-3, 2011 in Partnership with National Jewish Health and France Foundation CHICAGO, Oct. 27 /PRNewswire-USNewswire/ -- The Pulmonary Fibrosis Foundation (PFF) today announced that it is establishing a national scientific conference for idiopathic pulmonary fibrosis (IPF) physicians and patients beginning in 2011. IPF Summit 2011: From Bench to Bedside, will be held at the Marriott Magnificent Mile in Chicago, IL...
DENVER, July 15 /PRNewswire-USNewswire/ -- For the 13th consecutive year, National Jewish Health has been named the #1 respiratory hospital in the nation by U.S. News & World Report. (Logo: http://www.newscom.com/cgi-bin/prnh/20080711/DC27335LOGO) (Logo: http://photos.prnewswire.com/prnh/20080711/DC27335LOGO) "We are gratified to receive this honor once again," said Michael Salem, MD, President and CEO of National Jewish Health. "It is a testimony to our outstanding faculty and staff...
BRISBANE, Calif., Sept. 17 /PRNewswire-FirstCall/ -- InterMune, Inc. (Nasdaq: ITMN) today announced that it will be collaborating with National Jewish Health(R)( )investigators in order to help further the research of inherited genetic factors that may play a role in idiopathic pulmonary fibrosis (IPF). InterMune will provide researchers at National Jewish with access to DNA collected from patients who participated in the Company's Phase 3 clinical trials in IPF for both pirfenidone...
